← Back to Search

Renal Denervation System

Renal Denervation for High Blood Pressure (RADIANCE-II Trial)

N/A
Waitlist Available
Led By Ajay Kirtane, MD, SM
Research Sponsored by ReCor Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Previously or currently prescribed antihypertensive therapy
Be older than 18 years old
Must not have
Primary pulmonary hypertension
Chronic oxygen support or mechanical ventilation other than nocturnal respiratory support for sleep apnea
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is testing whether the Paradise System, a new treatment for hypertension, is effective and safe. The trial will enroll people who have Stage 2 hypertension and are not currently taking any medication for their hypertension.

Who is the study for?
This trial is for adults with Stage II hypertension, who have been on 0-2 blood pressure medications. They should have a documented high blood pressure range and can't be on chronic oxygen support or have severe cardiovascular issues. Pregnant individuals or those with uncontrolled diabetes are excluded.
What is being tested?
The study tests the Paradise System's safety and effectiveness in lowering blood pressure compared to a renal angiogram procedure. Participants will either receive the Paradise treatment or undergo an angiogram without denervation.
What are the potential side effects?
Potential side effects may include discomfort at the catheter insertion site, bruising, bleeding, kidney artery damage, elevated blood pressure post-procedure, and possible impacts on kidney function.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been prescribed medication for high blood pressure.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have high blood pressure in the lungs.
Select...
I need oxygen or a ventilator during the day, not just for sleep apnea at night.
Select...
My kidney arteries are not suitable for treatment.
Select...
I have Type I diabetes or my Type II diabetes is not under control.
Select...
My kidney function is low.
Select...
I have high blood pressure not caused by sleep apnea or treated conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Renal DenervationExperimental Treatment1 Intervention
Renal Angiogram and Renal Denervation (Paradise Renal Denervation System)
Group II: Sham ControlPlacebo Group1 Intervention
Renal Angiogram

Find a Location

Who is running the clinical trial?

ReCor Medical, Inc.Lead Sponsor
10 Previous Clinical Trials
4,941 Total Patients Enrolled
Ajay Kirtane, MD, SMPrincipal InvestigatorColumbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation
2 Previous Clinical Trials
2,305 Total Patients Enrolled
Prof. Michel Azizi, MD, PhDPrincipal InvestigatorProfessor of Vascular Medicine, Hypertension Dept. and Clinical Investigation Center, Hôpital Européen Georges Pompidou

Media Library

Paradise Renal Denervation System (Renal Denervation System) Clinical Trial Eligibility Overview. Trial Name: NCT03614260 — N/A
High Blood Pressure Research Study Groups: Renal Denervation, Sham Control
High Blood Pressure Clinical Trial 2023: Paradise Renal Denervation System Highlights & Side Effects. Trial Name: NCT03614260 — N/A
Paradise Renal Denervation System (Renal Denervation System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03614260 — N/A
~33 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top